Stifel Upgrades Treace Medical Concepts to Buy From Hold
Stifel has upgraded Treace Medical Concepts, Inc. from a 'Hold' to a 'Buy' rating and increased its price target to $6.50.
Stocks · News reference
8-K filing — TREACE MEDICAL CONCEPTS, INC. (TMCI)
Filed: 2026-11-06 AccNo: 0001193125-26-450715 Size: 751 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
This AMD Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Analysts upgraded Treace Medical, AMD, Airbnb, and/or price targets.
Treace Medical Concepts, Inc. Reports Third Quarter 2026 Financial Results
Treace Medical Concepts reported its third quarter 2026 financial results, highlighting a reduction in net loss and updated full-year 2026 revenue guidance.
Treace Medical Announces Launch of Tailorplasty™ MIS Tailor's Bunion Correction System
Treace Medical Concepts has completed the first surgical cases using its new Tailorplasty™ MIS system for correcting bunionettes.
Treace Medical Concepts, Inc. to Present at the Stifel 2026 Healthcare Conference
Treace Medical Concepts, Inc. announced it will participate in the Stifel 2026 Healthcare Conference on November 11, 2026.
Treace to Report Third Quarter 2026 Financial Results on November 6, 2026
Treace Medical Concepts, Inc. has scheduled the release of its financial results for the third quarter of 2026 for November 6, 2026.